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CADASIL disease belongs to the group of rare dis-
eases. It is well established that the Notch3 protein is 
primarily responsible for the development of CA-
DASIL syndrome. Herein, we attempt to shed light to 
the actual molecular mechanism underly-
ing CADASIL via insights that we have from prelimi-
nary in silico and proteomics studies on the Notch3 
protein. At the moment, we are aware of a series of 
Notch3 point mutations that promote CADASIL. In 
this direction, we investigate the nature, extent, phys-
icochemical and structural significance of the mutant 
species in an effort to identify the underlying mecha-
nism of Notch3 role and implications in cell signal 
transduction. Overall, our in silico study has revealed a 
rather complex molecular mechanism of Notch3 on the 
structural level; depending of the nature and position 
of each mutation, a consensus significant loss of beta-
sheet structure is observed throughout all in 
silico modeled mutant/wild type biological systems. 
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A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling 
and evolutionary analyses 
Introduction 
 
CADASIL stands for Cerebral Autosomal Dominant 
Arteriopathy Subcortical Infarcts Leukoencephalopa-
thy. In other words, cerebral relates to the brain, auto-
somal dominant to the inheritance pattern, arteriopathy 
to arterial disease (in this case within the brain), sub-
cortical to the area of the brain involved in higher 
functioning, infarcts to tissue necrosis due to a lack of 
oxygen and leukoencephalopathy to myelin damage in 
the brain (Joutel et al. 1996). CADASIL is also known 
as hereditary multi-infarct dementia, familial disorder 
with subcortical ischemic strokes and familial 
Binswanger’s disease. 
 This disease is the most prevalent type of he-
reditary cerebral angiopathy (Sourander & Walinder 
1977) or stroke disorder, and mutations of the 
NOTCH3 gene located on chromosome 19 are re-
garded as its main cause. It belongs to a family of dis-
orders called leukodystrophies (Chabriat et al. 1995, 
Joutel et al. 1996). More than 30 years have passed 
since the first time the condition was described in a 
Swedish family. However, the acronym CADASIL did 
not come out until the early 1990s (Sourander & 
Walinder 1977, Tournier-Lasserve et al. 1993). Most 
patients with CADASIL have a family member with 
the disorder. However, there have been cases reported 
where a patient has no first-degree relative with CA-
DASIL symptoms (Joutel et al. 2000). Nevertheless, as 
genetic testing for this disease was developed after 
2000, many cases were misdiagnosed as different neu-
rodegenerative disorders (Razvi et al. 2005). 
 This inherited condition mainly affects the 
small arteries in the white matter of the brain, causing 
thickening of their walls that, consequently, blocks the 
blood flow. The poorer blood supply can cause areas 
of tissue death; for example, multiple lacunar and sub-
cortical white matter infarctions. The vascular smooth 
muscle (VSM) cells surrounding the arteries become 
abnormal and gradually die. Disproportionate cortical 
hypometabolism has also been reported (Tatsch et al. 
2003). 
 The most common first sign of CADASIL is 
migraines, often followed by visual sensations or 
auras, usually at the age of 20-30. However, the most 
usual symptom, which has also been reported as a first 
sign in some cases, is the ischemic episodes, which 
include Transient Ischemic Attacks (TIAs) and  
strokes. Strokes appear for the first time between the 
ages of 30 and 50, while TIAs usually occur prior to 
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them. Individuals with CADASIL may suffer recurrent 
strokes (subcortical cerebral infarctions) (Sourander & 
Walinder 1977) throughout their lifetime that damage 
the brain as time goes by. Strokes can cause paralysis 
like pseudobulbar palsy (Chabriat et al. 1995, Dalkas 
et al. 2013), loss of sensation, walking problems or 
slurred speech, while recurrent ischemic episodes may 
lead to urinary incontinence or severe disability. The 
strokes that appear in the subcortical area of the brain, 
associated with reasoning and memory, are also re-
sponsible for cognitive function problems. Cognitive 
deterioration progresses to difficulties with concentra-
tion, attention or loss of intellectual function (Toni-
Uebari 2013). Approximately 70% of the patients over 
65 years old suffer from subcortical dementia, which 
appears with slowing of motor function, loss of mem-
ory or apathy.  Furthermore, almost 10-20% of the pa-
tients demonstrate psychiatric disorders, sometimes 
even as a first symptom. Such disorders include mood 
or perception changes (mania or depression), changes 
in personality, hallucinations, delusions, anxiety and 
panic disorders (Valenti et al. 2011). Rarely, CA-
DASIL also causes recurrent epileptic seizures (5-10% 
of patients) (Buffon et al. 2006, Dichgans et al. 1998, 
Velizarova et al. 2011). Leukoencephalopathy is diag-
nosed through magnetic resonance imaging (MRI) as 
diffuse white matter lesions (Ueda et al. 2009). 
 The onset of cerebrovascular disease usually 
occurs in the mid-adult (30s-60s), while recurrent tran-
sient ischemic attacks (TIAs) or strokes in multiple 
vascular territories appear between 30-50 years of age. 
Symptoms and disease onset can vary widely (Chabriat 
et al. 1995).  
 
The Notch3 Protein 
 
In general, Notch genes encode receptors that arbitrate 
short-range signalling events. A typical Notch gene 
encodes a single-pass transmembrane receptor protein 
(Fiuza & Arias 2007, Sourander & Walinder 1977). 
 In particular, the NOTCH3 gene was identified 
in the early 90s and its expression was first identified 
in proliferating neuroepithelium (Bellavia et al. 2008). 
It provides instructions for generating the Notch3 re-
ceptor protein, found on the surface of VSM cells 
(Tikka et al. 2009). Upon Notch3 receptor activation, a 
signaling cascade is initiated resulting in the regulation 
of specific genes. In the case of VSM cells, Notch3 
receptors play a pivotal role in the optimal functional-
ity, survival and maintenance of muscle cells in the 
arterial network of the brain.  
 The NOTCH3 gene is located on the short (p) 
arm of chromosome 19 between positions 13.2 and 
13.1 (cytogenetic location), as retrieved from NCBI 
database (Gene ID: 4854). More precisely, the molecu-
lar location of NOTCH3 gene is between the base pairs 








A Blast search, with the Notch 3 protein sequence was 
performed at the European Bioinformatics Institute 
(EBI), to find similar sequences in the Uniprot data-
base (Consortium 2011). All sequences with an E-
value lower than 7.0E-4 were selected to perform an 
analysis with the Multiple EM for Motif Elicitation 
(MEME) software (Papageorgiou et al. 2014, Papan-
gelopoulos et al. 2014). The analysis was performed at 
http://meme.sdsc.edu/meme4_6_1/ using default val-
ues. Logos for the found motifs were generated using 
the WebLogo software (Crooks et al. 2004). 
 
Medical Data 
A list of point mutations of the Notch3 protein was 
gracefully provided by Prof. Marc Baumann, the Bio-
medicum Helsinki Unit. Table 1 summarizes the point 
mutations examined in this study.  
 
Homology Modelling and Energy Minimization  
Homology modelling for the Notch3 protein was car-
ried out using Modeller (Sali 1995). The structure of 
the Human Notch1 EGFS structure was used as tem-
plate for this study (PDB entry: 2VJ3) (Cordle et al. 
2008). Subsequent energy minimization was per-
formed using the Gromacs-implemented, Charmm27 
forcefield (Vlachakis et al. 2013a, b). Models were 
structurally evaluated using the Procheck utility 
(Laskowski 1996, Vlachakis et al. 2013c). Energy 
minimizations were used to remove any residual geo-
metrical strain in each molecular system, using the 
Charmm forcefield as it is implemented into the Gro-
macs suite, version 4.5.5 (Hess et al. 2008, Pronk et al. 
2013). All Gromacs-related simulations were per-
formed through our previously developed graphical 
interface (Sellis et al. 2009, Vlachakis et al. 2013d). 
An implicit Generalized Born (GB) solvation was cho-
sen at this stage, in an attempt to speed up the energy 
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A Arg107Trp Canadian case, previously unreported (data pro-
vided by Prof. Baumann) 
B Ser497Leu 
Reported in the ESP database (NHLBI GO 
Exome Sequencing Project) (data provided by 
Prof. Baumann) 
C Glu813Lys 
Reported in the ESP database (NHLBI GO 
Exome Sequencing Project) (data provided by 
Prof. Baumann) 
D Ala1020Pro Scheid et al. 2008 
E Ser978Arg Ferreira et al. 2007 
F His1133Glu Canadian case (data provided by Prof. Baumann) 
Table 1. Point mutations examined in the current study. 
minimization process (Vlachakis & Kossida 2014). 
 
Molecular Dynamics Simulations 
Molecular systems of the Notch3 protein were sub-
jected to unrestrained Molecular Dynamics simulations 
(MDs) using the Gromacs suite, version 4.5.5 (Hess et 
al. 2008, Pronk et al. 2013, Vlachakis et al. 2014). 
MDs took place in a SPC water-solvated, periodic en-
vironment. Water molecules were added using the 
truncated octahedron box extending 7Å from each 
atom. Molecular systems were neutralized with 
counter-ions as required. For the purposes of this study 
all MDs were performed using the NVT ensemble in a 
canonical environment, at 300 K, 1 atm and a step size 
equal to 2 femtoseconds for a total 500 nanoseconds 
simulation time (Balatsos et al. 2012, Vlachakis et al. 
2012b, 2013f, g). An NVT ensemble requires that the 
number of atoms, volume and temperature remain con-
stant throughout the simulation (Vlachakis et al. 
2012a, 2013e). 
 
Results & Discussion 
 
Molecular Mechanism 
More than 190 mutations in the NOTCH3 gene have 
been found to cause CADASIL (Tournier-Lasserve et 
al. 1993). The gene encodes a large transmembrane 
(Notch3) receptor protein (Joutel et al. 1996), which 
has a crucial role within the vascular smooth muscle 
signaling pathways. It is comprised of 33 exons 
(Monet-Leprêtre 2009). At the molecular level, all 
pathogenic mutations have been found to result in an 
odd number of cysteine residues (which stay unpaired, 
due to addition or deletion of a cysteine molecule) in 
one of the 34 epidermal growth factor (EGF)-like re-
peats that are present in the extracellular domain 
(N3ECD). This results in misfolding of the Notch3 
protein. NOTCH3 is expressed in VSM cells and this 
misfolding leads to a gradual accumulation of N3ECD 
on their surface, resulting in their degeneration. Apart 
for N3ECD accumulation, there is also granular os-
miophilic material (GOM) deposited in the walls of the 
vessels. These two features can only be found in CA-
DASIL (Ishiko et al. 2006, Lewandowska et al. 2011, 
Valenti et al. 2011). 
 Various neurodegenerative diseases have pre-
sented the key pathological feature of aggregation and 
accumulation of misfolded proteins. It was recently 
reported that Notch3 multimerization is enhanced by 
the presence of CADASIL-associated mutations. In the 
case that GOM deposits contain N3ECD, the mutated 
Nothc3 protein oligomers that are formed may be the 
lodgements of GOM. Degradation does not affect mu-
tant Notch3 aggregates and their formation may cause 
cellular dysfunction and/or cell death. However, VSM 
cell degeneration and loss may not be the only cause of 
blood vessel wall deterioration in CADASIL patients. 
Other factors contributing to this process may include 
hyalinization of the vessels, fibrosis and an abnormal 
increase in the intercellular space at the vessel wall 
(Ishiko et al. 2006, Lewandowska et al. 2011, Valenti 
et al. 2011). 
 However, recently some non-Cys mutations 
have been reported. Those mutations do not follow the 
characteristic pathology and pattern of the disease. 
Furthermore, it has been identified that some of the 
non-Cys mutations cause GOM whereas others do not 
(Bersano et al. 2012). 
 
AAR Pattern 
Amino Acid Repeats (AARs) can be  frequently found 
within protein sequences and play various roles in pro-
tein function and evolution. Therefore, the identifica-
tion of AAR patterns usually serves as the first step for 
further investigation. Various algorithms have been 
developed to assist in this identification. However, in 
this case, a pattern was identified solely through obser-
vation. 
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Figure 1. Repeating pattern of the Notch3 protein sequence, 
divided into repeats, based on the highlighted conserved 
residues, followed by a Weblogo representing the repeating 
motif. 
 The whole Notch3 protein sequences as re-
trieved from the NCBI protein database is comprised 
of 2321 amino acids. However, the repeating pattern 
appears among 1461 amino acids (Figure 1). The latter 
sequence was divided into 34 most similar repeats and 
another 3 that demonstrate only partial similarity, as 
shown. From the last repeat to the end, no pattern is 
observed. 
 The alignment was based on the residues high-
lighted on the sequence. The repeating motif is obvi-
ous. The conserved positions which supported the 
forming of the pattern are apparent on the logo follow-
ing the sequence (Figure 1). 
After having mapped all the point mutations on 
the sequence of Notch3, as they have been reported 
from cases examined by Prof. Baumann, the resulting 
secondary structure is shown in Figure 2. The selected 
residues represent the mutation positions. The repeat-
ing pattern of the mutation positions is obvious in this 
representation as well. The red arrows indicate the 3 
disulphide bonds that are followed by 3 hydrogen 
bonds. The pattern is repeated 3 times. 
As the mutations appear at specific locations on 
the secondary structure, it is assumable that these loca-
tions serve specific purposes, structure-wise, for the 
Notch3 protein function. 
 
Description of Pattern 
As shown in Figure 3A (color distribution of residues 
based on classification according to structure and 
chemical characteristics) and 3B (color distribution of 
residues based on side-chains, charge and hydropho-
bicity), the repeating pattern starts with a highly con-
served proline (pos. 1) which appears on a coil-coil 
conformation on the secondary structure, followed by 
a cysteine (pos. 2) almost conserved. Cys residues are 
responsible for the formation of disulphide bonds, 
which affect the proper folding and biological function 
of a protein. The high appearance of mutations on Cys 
residues, which are mostly conserved, in Notch3 se-
quence accounts for misfolding and loss of function 
that may lead to CADASIL disease. The succession of 
two contiguous higly conserved Gly residues (pos. 5 
and 6) constitutes a flexible linker between the two 
conserved Cys residues (pos. 2 and 8) providing pro-
tein stability at that point (Robinson & Sauer 1998, 
Yan & Sun 1997). The position of the second Gly 
(pos. 6) seems to be an aliphatic conserved residue, as 
it is mainly either Gly or Ala. However, Ala does not 
appear so frequently due to its bulky side chain. On 
positions 13-17, although not higly conserved, Gly 
residues are mostly observed, forming a flexible linker 
once again. The appearance of aromatic residues (F, Y, 
W) (pos. 18 and 26) right after Gly (pos. 17 and 25) on 
the strand of the beta sheet on the secondary structure 
is also noticable. Aromatic residues provide favorable 
interaction energy through cross-strand pairing with 
glycine in order to reduce glycine’s destabilizing effect 
(Merkel & Regan 1998). These positions appear con-
served by hydrophobic residues (F, Y, A, W, Y) as 
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Figure 2. 3D structure of Notch3 protein. The selected resi-
dues represent all the point mutations reported by Prof. 
Baumann. The pattern is obvious in the secondary structure 
and is repeated 3 times (number above). 
Figure 3. Weblogo representing conserved Notch3 protein 
repeats. (A) Color distribution based on structure and chemi-
cal characteristics of residues (green: aliphatic, blue: hy-
droxyl or sulfur-containing, red: cyclic, black: basic, purple: 
aromatic, yellow: acidic & their amide). (B) Color distribu-
tion based on side-chains, charge and hydrophobicity of 
residues (purple: positively charged, black: negatively 
charged, red: uncharged, blue: special cases, green: hydro-
phobic). 
well. The Cys-X-Cys motif (pos. 20-22) that follows is 
completely conservative and is a strong pattern respon-
sible for catalysis of redox reactions (Zhang et al. 
2008). The two contiguous prolines right afterwards 
(pos. 23, 24), due to their cyclic character, seem to aid 
in the formation of the beta turn on the secondary 
structure. The amino acid sequence that follows con-
tains two quite conservative glycines (pos. 25 and 28), 
which substitute the smallest amino acid with the sim-
plest side chain of a hydrogen molecule. These two 
glycines are separated by aromatic residues (F, Y, W) 
(pos. 26) that have bulky side chains and others with 
hydroxyl-containing or acidic side chains (T, S, Q, D, 
E) (pos. 27) that are likely to participate in H-bonding. 
Position 27 seems to be mostly conserved by un-
charged residues (T, S, Q). On positions 31-38, the 
sequence starts and ends with conserved cysteines with 
hydrophilic residues (E, D, N) in between, interrupted 
only by an aliphatic hydrophobic residue (V, I, A) on 
position 35. This region seems to be exposed to the 
solvent due to its hydrophilic character. Residues Asp 
and Glu seem equally replaced by one another at this 
region, as they are both negatively charged. The high 
content of Gly and Pro in Notch3, as well as their con-
servation score in the sequence, serve critical roles for 
the protein’s formation into elastomeric or amyloid 
fibrils. This finding stands of great significance as 
amyloid fibrils are inextricably connected with tissue-
degenerative diseases, such as CADASIL. 
 
Protein Structure 
The Notch extracellular domain is composed of a con-
served array of up to 36 epidermal growth factor 
(EGF)-like repeats, that contribute to ligand interac-
tion, as well as three Lin-12-Notch (LN) repeats, 
which are juxtamembrane repeats responsible for inter-
actions between the extracellular and intracellular do-
mains. The intracellular domain of Notch comprises of 
seven ankyrin repeats together with a PEST (proline, 
glutamine, serine, threonine-rich) and a TAD 
(transactivation) domain. The C-terminal heterodimeri-
zation domain is a hydrophobic region of extracellular 
Notch, able to create a stable complex with the ex-
tracellular domain of transmembrane Notch. The 
cleavage of the Notch receptor occurs at the S1 site 
within the trans-Golgi network, during the secretion 
process. The process of cleavage as well as the result-
ing structure are vital for Notch function in mammals. 
At the surface of the cell, Notch can interact with 
its ligands, either Delta or Serrate. This interaction 
sheds the ectodomain and makes the Notch protein 
vulnerable to further cleavages. Following 3 different 
cleavages (S2-S4), the intracellular domain of the re-
maining Notch fragment is released and translocates to 
the nucleus where it modulates gene expression by 
acting as a co-activator of the transcription factor sup-
pressor of hairless (Fiuza & Arias 2007). 
The negative regulatory region of the Notch re-
ceptor, which can be found between the ligand-binding 
and transmembrane domains, is essential for protecting 
the Notch receptor against cleavage, when no ligand is 
present. This region includes three cysteine-rich LIN-
12–Notch repeats and a ‘heterodimerization domain’, 
which comes right before the membrane and contains 
both the S1 and S2 cleavage sites. Several studies, over 
a long time, drove to the conclusion that the negative 
regulatory region functions as the regulatory switch to 
activate the receptor. Receptors missing the EGF-like 
repeats remain functionally inactive. However, delet-
ing the LIN12-Notch repeats or point mutations in this 
area have been reported to result in gain-of function 
phenotypes as well as ligand-independent metallopro-
tease cleavage (Gordon et al. 2008). 
The NOTCH proteins, i.e. NOTCH1-4, consist of 
34 EGF-like repeats and work as receptor for Jagged 
and Delta ligands. They can function as both trans-
membrane receptors and transcription factors. Upon 
activation and subsequent release of the notch intracel-
lular domain (NICD), they effect cellular differentia-
tion and proliferation, during development and adult 
life, including homeostasis in adult tissues (Boucher et 
al. 2012, Fiuza & Arias 2007, Gordon et al. 2008). 
 
Molecular Modelling of Notch3 3D Structure 
In order to understand the consequences for the 
NOTCH3 protein when introducing amino acid 
changes, we took a homology modelling approach 
since no structure has been determined for this protein. 
Using Modeller, Notch3 was modelled and its in silico 
3D structure was established (Sali 1995). Moreover, 
the consequence of the introduced mutations could 
also be predicted via molecular dynamics simulations 
using Gromacs (Hess et al. 2008). Modeller predicted 
a set of two anti-parallel beta-sheet network in ar-
ranged repeats across the Notch3 protein. One pair is 
short, made up of 5 to 6 residues, while the other one 
is longer as it consists of almost 10 to 12 residues. The 
beta-sheets are held together by beta turns and coil 
fragments that contain mainly non-hydrophobic amino 
acids. A set of strategically positioned cysteine resi-
dues is responsible for the structural integrity of the 
Notch3 structure via disulphide bridges (Figure 4). 
The induced R107W mutation provoked the par-
tial loss of structure of one of the beta sheets in the 
long pair antiparallel conformation of Notch3. The 
position of the 107 residue was most likely crucial for 
the proper formation of the first antiparallel set of 
sheet-loop-sheet, as it was modelled to be located right 
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in the middle of the connecting loop. The bulky and 
conjugated side chain of the Tryptophan is pushed 
away from the core of the protein. Therefore it is found 
to claim the available space in the same plane that the 
two beta sheets define. As a result, the protein back-
bone in the proximity of the 107 position is twisted 
and converted to a coil conformation, having lost its 
original beta-sheet planarity (Figure 4A). 
The S497L mutation was predicted to lead to a 
partial loss of the first long pair of beta-sheet forma-
tions, as it significantly changes the unstructured coil 
conformation it belongs to, to an almost perpendicular 
to the beta-sheet plane structure. As a result the net-
work of hydrogen bonds in the nearby anti-parallel 
beta sheet pair is lost, the gap between the secondary 
elements becomes slightly bigger and inevitably one of 
the beta-sheets collapses and loses more than half of its 
structure (Figure 4B). 
The same structural principle applies to the 
E813K mutation. The negatively charged glutamic 
acid residue was predicted to actively establish hydro-
gen bonds to the residues in close proximity that stabi-
lise the nearby pair of beta sheets. The induced E813K 
mutation introduces a bulky lysine residue in the origi-
nal glutamic acid position that was modelled to induce 
breakage of the contact between the two upper beta-
sheets. The obvious reason behind this change is attrib-
uted to the physicochemical change of the side chain 
from negatively to positively charged, in the case of 
the lysine, and to the fact that the lysine is slightly lar-
ger in size than the glutamic acid amino acid. It seems 
the available room is not big enough to accommodate 
an amino acid larger than glutamic acid (Figure 4C). 
The A1020P mutation leads to a significant loss 
of structure of the nearby beta-sheet arrangement of 
the Notch3 structure. Even though the 1020P residue is 
found on a coil-coil structural conformation, the phi/
psi dihedral angles of the amino acids involved are 
very close to a-helical Ramachandran plot regions. 
Proline cannot establish a hydrogen bond via its back-
bone amine residue since it has no amide hydrogen.  
However, even though proline has very poor alpha-
helix-forming tendency, it is quite often seen as the 
first or last residue of an alpha-helix, presumably due 
to its structural rigidity as its side chain forms a ring. 
Alanine on the other hand belongs to a group of amino 
acid residues with low helix forming propensity. In 
this case, it seems that the induced proline is trying to 
stabilize an almost alpha-helical local conformation for 
the small stretch of loop it sits on. Consequently, the 
structural shift is too great for the nearby beta-sheets to 
sustain and they collapse, thus losing most of their 
structure (Figure 4E) 
The S978R mutation also leads to loss of beta-
sheet structure from Notch3. The Arginine 978 was 
predicted to be outside of the beta-sheet formation 
since there is no space available to accommodate it. 
However, the tiny side chain of the original serine resi-
due was small enough to allow the loop to further bend 
backwards in favor of the beta-sheet formation. As a 
result of the induced arginine residue the phi/psi dihe-
dral angle geometry of the nearby residues changes 
and some residues of the first beta-sheet formation are 
converted to a coil structure (Figure 4D). 
The His1133E mutation is located on a beta-turn 
conformation that stabilizes the short pair of the anti-
parallel beta sheets. The negatively charged glutamic 
acid is drawn to the inner part of the Notch3 core via 
newly, randomly established hydrogen bonds to nearby 
residues. The positive charge of the Histidine’s imida-
zole ring was positioned in a neutral rotamer that al-
lowed the two beta sheets to interact through hydrogen 
bonding. The tilt of the glutamic acid’s side chain and 
the consecutive rearrangement of the backbone of the 
protein locally, prohibits the formation of one of the 
two beta sheets completely. As a result, the Notch3 
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Figure 4. Structural superposition of the wild type and mu-
tant type of Notch3 protein. Color coding is as follows: 
green for wild type and red for mutant, all shown in ribbon 
representation. (A) Arg107Trp, (B) Ser497Leu, (C) 
Glu813Lys, (D) Ser978Arg, (E) Ala1020Pro, (F) 
His1133Glu. 
protein is very much disorganized and locally almost 
denatured as it completely loses a vital secondary 




Herein, we presented an in silico study of a series of 
Notch3 mutations that have been recently identified. In 
most cases these mutations refer to a Cys residue that 
leads to another unpaired Cys residue. In some cases 
of this disease, we see accumulation of Granular Os-
miophilic Material (GOM), which has been a hallmark 
for the final diagnosis based on electron microcopy. 
However, recently some non-Cys mutations have also 
been identified. These mutations do not follow the 
characteristic pathology and pattern of the disease. 
Furthermore, it has been established that some of the 
non-Cys mutations cause GOM whereas some others 
do not. The ultimate aim of the in silico study was to 
establish, via the 3D structural analysis, an explanation 
of what actually happens in these cases. In this direc-
tion, exhaustive molecular dynamics simulations 
showed that these non-Cys mutations trigger signifi-
cant loss of structure in the Notch3 protein, compared 
to the wild type. Even though these are mainly point 
mutations, we have established that the effect of each 
one of them on the three dimensional structure of the 
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